Haojie Huang Selected Research

Precision Medicine

12/2022	Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma.
1/2021	Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haojie Huang Research Topics

Disease

76	Neoplasms (Cancer) 12/2023 - 02/2002
73	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2002
16	Carcinogenesis 12/2022 - 02/2005
9	Inflammation (Inflammations) 10/2023 - 01/2013
7	Adenocarcinoma 10/2023 - 01/2018
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 03/2010
7	Neoplasm Metastasis (Metastasis) 11/2019 - 05/2011
5	Chronic Pancreatitis 10/2023 - 03/2010
5	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 01/2021
4	Pancreatitis 01/2023 - 01/2013
4	Retinoblastoma (Glioblastoma, Retinal) 01/2023 - 03/2004
3	COVID-19 01/2023 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 12/2012
3	Disease Progression 02/2015 - 05/2011
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2024 - 01/2022
2	Fibrosis (Cirrhosis) 10/2023 - 12/2013
2	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 01/2023
2	Chromosomal Instability (Chromosome Stability) 01/2023 - 01/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 07/2016
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2018
2	Metaplasia 11/2019 - 01/2019
1	Kidney Neoplasms (Kidney Cancer) 03/2024
1	Gallstones (Gallstone) 01/2024
1	Cholelithiasis 01/2024

Drug/Important Bio-Agent (IBA)

35	Androgen Receptors (Androgen Receptor)IBA 10/2023 - 01/2002
31	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
26	AndrogensIBA 12/2023 - 01/2002
12	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2002
11	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 02/2014
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2017
6	EnzymesIBA 01/2022 - 03/2016
6	Histones (Histone)IBA 01/2021 - 04/2014
5	Androgen Antagonists (Antiandrogens)IBA 10/2023 - 02/2014
5	enzalutamideIBA 10/2023 - 06/2016
5	Messenger RNA (mRNA)IBA 01/2022 - 02/2002
5	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2009
5	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2016
4	Phosphotransferases (Kinase)IBA 01/2023 - 11/2011
4	Hormones (Hormone)IBA 01/2023 - 05/2015
4	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 09/2015
4	Retinoblastoma ProteinIBA 01/2023 - 03/2004
4	Fructose-BisphosphataseIBA 01/2022 - 01/2017
4	Forkhead Box Protein O1IBA 01/2019 - 02/2005
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2022
3	palbociclibIBA 01/2023 - 01/2018
3	Long Noncoding RNAIBA 01/2023 - 12/2015
3	MethyltransferasesIBA 01/2023 - 04/2014
3	InterferonsIBA 01/2022 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
3	Enhancer of Zeste Homolog 2 ProteinIBA 01/2021 - 11/2010
3	UbiquitinIBA 01/2021 - 02/2005
3	Ligases (Synthetase)IBA 01/2021 - 02/2005
3	abirateroneIBA 01/2018 - 08/2017
2	Fumarate Hydratase (Fumarase)IBA 03/2024 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 01/2023
2	calcium silicate (Wollastonite)IBA 10/2023 - 01/2022
2	Glutathione (Reduced Glutathione)IBA 10/2023 - 01/2021
2	Neutralizing AntibodiesIBA 01/2023 - 12/2016
2	6-methyladenineIBA 01/2023 - 01/2023
2	Antisense OligonucleotidesIBA 01/2023 - 01/2019
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 09/2011
2	Estrogen ReceptorsIBA 06/2021 - 01/2021
2	Histone Deacetylase InhibitorsIBA 01/2021 - 04/2014
2	NEO2734IBA 01/2021 - 11/2019
2	Testosterone (Sustanon)FDA Link 01/2021 - 01/2018
2	Gemcitabine FDA Link 01/2021 - 01/2017
2	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2018
2	Immune Checkpoint ProteinsIBA 01/2021 - 01/2020
2	LigandsIBA 07/2020 - 08/2017
2	CeruletideIBA 01/2020 - 01/2013
2	LipopolysaccharidesIBA 01/2020 - 10/2018
2	Lysine (L-Lysine)FDA Link 11/2019 - 01/2016
2	(+)-JQ1 compoundIBA 11/2019 - 01/2018
2	taxaneIBA 01/2019 - 01/2017
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 12/2013
2	Abiraterone AcetateIBA 01/2018 - 08/2017
2	hydrogen sulfite (bisulfite)IBA 01/2018 - 03/2010
2	ChromatinIBA 01/2018 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 08/2011
2	CarcinogensIBA 07/2016 - 12/2012
2	Enhancer RNAsIBA 06/2016 - 04/2016
2	p300-CBP-associated factorIBA 03/2016 - 03/2014
2	Cysteine (L-Cysteine)FDA Link 12/2012 - 03/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2010 - 11/2009
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2010 - 01/2002
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 02/2005 - 04/2004
1	MicroplasticsIBA 01/2024
1	CholesterolIBA 01/2024
1	Microphthalmia-Associated Transcription FactorIBA 12/2023
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2023
1	perovskiteIBA 10/2023

Therapy/Procedure

29	Therapeutics 01/2024 - 01/2002
28	Castration 12/2023 - 11/2009
5	Drug Therapy (Chemotherapy) 01/2023 - 11/2009
3	Injections 01/2020 - 01/2013
2	Precision Medicine 12/2022 - 01/2021
2	Immunotherapy 01/2021 - 01/2018
1	Cholecystectomy 01/2024
1	Lasers (Laser) 01/2024